ImmunoCellular Therapeutics, Ltd. filed its S-1 on Jun 24, 2022 for the period ending Dec 31, 2021. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 USD | +14.16% | +6.11% | -9.48% |
1st Jan change | Capi. | |
---|---|---|
-9.48% | 20.84M | |
+22.57% | 46.4B | |
-1.50% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.06% | 26.01B | |
-19.22% | 19.52B | |
+29.16% | 12.43B | |
+0.21% | 12.18B | |
-0.27% | 12.13B |
- Stock Market
- Equities
- IMUC Stock
- News EOM Pharmaceuticals Holdings, Inc.
- ImmunoCellular Therapeutics, Ltd. Auditor Raises 'Going Concern' Doubt